BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $328,000 | -77.6% | 2,364 | -84.3% | 0.02% | -77.5% |
| Q2 2021 | $1,466,000 | +431.2% | 15,099 | +255.0% | 0.08% | +110.5% |
| Q3 2020 | $276,000 | -58.0% | 4,253 | -52.7% | 0.04% | -64.5% |
| Q2 2020 | $657,000 | -7.7% | 8,984 | -47.4% | 0.11% | -0.9% |
| Q3 2019 | $712,000 | +101.1% | 17,064 | +110.8% | 0.11% | +129.8% |
| Q2 2019 | $354,000 | -68.0% | 8,094 | -62.3% | 0.05% | -69.7% |
| Q1 2019 | $1,106,000 | +261.4% | 21,484 | +159.4% | 0.16% | +171.9% |
| Q4 2018 | $306,000 | – | 8,282 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |